Overview of Dr. Faiena
Dr. Izak Faiena is an urologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian/Hudson Valley Hospital, NewYork-Presbyterian/Columbia University Irving Medical Center, and James J. Peters Veterans Affairs Medical Center. He received his medical degree from Albert Einstein College of Medicine of Yeshiva University and has been in practice 7 years. He is one of 11 doctors at James J. Peters Veterans Affairs Medical Center and one of 62 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Urology. He has more than 90 publications and over 500 citings.
Office
161 Fort Washington Avenue
New York, NY 10032
Education & Training
- Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Urology, 2012 - 2016
- Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Surgery, 2010 - 2012
- Albert Einstein College of MedicineClass of 2010
- Yeshiva UniversityB.A., Biology, Summa Cum Laude, 2006
Certifications & Licensure
- NJ State Medical License Current
- NY State Medical License 2019 - 2026
- CA State Medical License 2015 - 2019
- American Board of Urology Urology
Awards, Honors, & Recognition
- Resident Research Award, Division of Urology 2015
- Resident Research Award for Best Oral Presentation RWJMS, 2014
- Excellence in Leadership Award Albert Einstein College of Medicine, 2010
- Join now to see all
Publications & Presentations
PubMed
- Assessing olaparib efficacy in U.S. Veterans with metastatic prostate cancer utilizing a time-indifferent g-rate method ideal for real-world analyses.Harshraj Leuva, Mengxi Zhou, Nader Jamaleddine, Mina Meseha, Izak Faiena
Ebiomedicine. 2024-09-01 - Gene and Protein Expression of MAGE and Associated Immune Landscape Elements in Non-Small-Cell Lung Carcinoma and Urothelial Carcinomas.Izak Faiena, Sabina Adhikary, Colleen Schweitzer, Stephanie H Astrow, Tristan Grogan
Journal of Immunotherapy. 2024-08-22 - Assessment of PSA responses and changes in the rate of tumor growth (g-rate) with immune checkpoint inhibitors in US Veterans with prostate cancer.Harshraj Leuva, George Moran, Nader Jamaleddine, Mina Meseha, Mengxi Zhou
Seminars in Oncology. 2024-05-11
Journal Articles
- Detection of Individual Prostate Cancer Foci via Multiparametric Magnetic Resonance ImagingSteven S Raman, Sohrab A Mirak, Izak Faiena, Aydin Pooli, Amirali Salmasi, Ely R Felker, European Urology
- Radical Prostatectomy Then and Now: Surgical Overtreatment of Prostate Cancer Is Declining from 2009 to 2016 at a Tertiary Referral CenterAmirali Salmasi, Izak Faiena, Karim Chamie, Urologic Oncology
- Impact of Uncontrolled Diabetes on Outcomes after Cystectomy in Patients with Bladder Cancer: A Population-based StudyFaiena I, Dombrovskiy VY, Sultan RC, Salmasi AH, Singer EA, Weiss RE, Clinical Genitourinary Cancer, 1/1/2016
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- From Moon Rocks to Kidney Stones: A Look at the Evolution of the CyberWandRutveej Patel, Izak Faiena, Sammy E. Elsamra, AUA National Meeting, 1/1/2016
- Outcomes of Men with Locally Advanced or Regionally Advanced Prostate Cancer Following Conservative Management (CM)Parth Modi, Izak Faiena, Neal Patel, Shunhua Shen, Eric A. Singer, Dirk Moore, Robert DiPaola, Grace Lu-Yao, Isaac Y. Kim, Thomas L. Jang, AUA National Meeting, 1/1/2016
- Adrenalectomy for Benign and Malignant Disease: Utilization and Outcomes by Surgeon Specialty and Surgical ApproachIzak Faiena, Alexandra Tabakin, Jeffrey Leow, Neal Patel, Parth K. Modi, Amirali H. Salmasi, Benjamin I. Chung, Steven L. Chang, Eric A. Singer, AUA National Meeting, 1/1/2016
- Join now to see all
Authored Content
- Re: Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma After NephrectomyFebruary 2018
- Re: Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma After NephrectomyFebruary 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: